Version 1.1 · published August 2026
The Standard
Eight criteria for screening a United States peptide seller. Each criterion states a requirement, a check method, and what fails. The ledger records every seller against every criterion, with dates.
The Standard screens the seller, not the peptide. A criterion is checkable against the seller's own published material or a public register. Revisions are versioned; the changelog records every change.
The eight criteria, compared
Eight criteria read faster side by side than as eight separate sections. Each row links to its own full clause, printed in full below with its rationale and check method.
| Code | Requirement | What fails |
|---|---|---|
| S1 | A licensed United States clinician evaluates each order before any drug ships. The seller states this on its own pages. | A checkout that never mentions a clinician fails S1. A site selling peptides labeled for research fails S1 by design. |
| S2 | The product cannot be bought without a medical evaluation. Payment alone must not produce a shipment. | An add-to-cart button on a semaglutide vial fails S2. An intake form that is optional fails S2. |
| S3 | The seller names the pharmacy that fills its orders. The name must identify a real facility. | The phrase 'a licensed US partner pharmacy' names nothing and fails S3. So does silence. |
| S4 | A seller of compounded drugs says so plainly. The disclosure states that compounded products are not FDA-approved. | Marketing a compounded product under a brand drug's name with no compounding language fails S4. |
| S5 | The seller publishes analytical evidence for what it ships. A certificate of analysis or equivalent lot documentation qualifies. | The word 'lab-tested' with no reachable document fails S5. |
| S6 | A physical United States address for the operating business is disclosed on the site. | A contact form with no address fails S6. A PO box records as satisfied, with a note. |
| S7 | The price is published before intake or checkout begins. The number, not a starting-at tease behind a form. | The phrase 'see pricing after your consultation' fails S7. |
| S8 | No FDA enforcement action has stopped the seller from operating. Any warning letter naming the entity is disclosed on its record. | An injunction, consent decree, seizure, or closure that halts the business fails S8. A warning letter alone does not: it is recorded and dated on the seller record instead. |
Every criterion, in full
S1.Prescriber requirement
A licensed United States clinician evaluates each order before any drug ships. The seller states this on its own pages.
Check method
The seller's published pages are read for prescriber language. The claim is recorded with its URL and the date read.
What fails: A checkout that never mentions a clinician fails S1. A site selling peptides labeled for research fails S1 by design. Full criterion ›
S2.Prescription gating
The product cannot be bought without a medical evaluation. Payment alone must not produce a shipment.
Check method
The public order path is read up to, never past, the intake step. Add-to-cart commerce with no eligibility step fails.
What fails: An add-to-cart button on a semaglutide vial fails S2. An intake form that is optional fails S2. Full criterion ›
S3.Pharmacy identification
The seller names the pharmacy that fills its orders. The name must identify a real facility.
Check method
The seller's pages and terms are searched for a pharmacy presented as the filling facility. A name plus a state records as satisfied.
What fails: The phrase 'a licensed US partner pharmacy' names nothing and fails S3. So does silence. Full criterion ›
S4.Compounding disclosure
A seller of compounded drugs says so plainly. The disclosure states that compounded products are not FDA-approved.
Check method
Product and FAQ pages are read for the words compounded and FDA-approved. Placement must be reader-visible, not buried in terms.
What fails: Marketing a compounded product under a brand drug's name with no compounding language fails S4. Full criterion ›
S5.Analytical documentation
The seller publishes analytical evidence for what it ships. A certificate of analysis or equivalent lot documentation qualifies.
Check method
The seller's pages are searched for certificates, HPLC reports, or lot testing. The document must be reachable, not merely mentioned.
What fails: The word 'lab-tested' with no reachable document fails S5. Full criterion ›
S6.Business address
A physical United States address for the operating business is disclosed on the site.
Check method
Footer, contact, terms, and privacy pages are read for a street address. A registered-agent address records with a note.
What fails: A contact form with no address fails S6. A PO box records as satisfied, with a note. Full criterion ›
S7.Price disclosure
The price is published before intake or checkout begins. The number, not a starting-at tease behind a form.
Check method
Public pages are read for stated prices. A price shown only after sign-up records as failed.
What fails: The phrase 'see pricing after your consultation' fails S7. Full criterion ›
S8.Enforcement status
No FDA enforcement action has stopped the seller from operating. Any warning letter naming the entity is disclosed on its record.
Check method
The full FDA warning-letter index is downloaded and searched locally, with a known-positive control letter proving the search works. Hits are attributed by entity and address, never by name resemblance, then read to record what the letter alleges and whether the seller still operates.
What fails: An injunction, consent decree, seizure, or closure that halts the business fails S8. A warning letter alone does not: it is recorded and dated on the seller record instead. Full criterion ›